Từ điển y khoa

Thuật ngữ y khoa chuẩn hóa theo MeSH, ICD-11, SNOMED CT.

62,341 terms indexed

• C5776901,3-benzodioxole-5-propanol,alpha-methyl-5-acetateMeSH

  structure in first source

• C5729471,3-bis((3,4,5-trihydroxybenzoyl)oxy)naphthaleneMeSH
• C5718441,3-bis(1-methylbenzimidazol-2-yl)-2-oxapropaneMeSH
• C5778531,3-bis(1-thyminyl)-2-propanoneMeSH

  binds dsRNA; structure in first source

• C5774821,3-bis(3,5-dichlorophenyl)ureaMeSH

  COH - City of Hope; has antineoplastic activity

• C5680971,3-bis(4,6-dimethyl-1H-nicotinonitrile-1-yl)1,3-dioxy propaneMeSH

  structure in first source

• C5709111,3-bis(4-isobutyramidobenzamido)-2,4-bis(3-methoxy-4-(thiophene-2-carbonyloxy)phenyl)cyclobutane-1,3-dicarboxylic acidMeSH

  a glucagon-like peptide-1 receptor agonist; structure in first source

• C5821471,3-bis(N-2-(hydroxyethyl)lauroylamino)-2-hydroxypropaneMeSH

  an artificial ceramide used in cosmetics; structure in first source

• C5755801,3-bis(dicyanomethylidene)indanMeSH

  structure in first source

• C5734961,3-bis(pyridin-2-ylethynyl)benzeneMeSH

  negative modulator at metabotropic glutamate receptor 5; structure in first source

• C5615391,3-bis(thiophosphinoyl)indeneMeSH

  structure in first source

• C5608711,3-bisbenzylimidazoliumMeSH

  has antioxidant activity; structure in first source

• C5723881,3-di(4-antipyrine)amideMeSH

  structure in first source

• C5763161,3-di-p-nitrophenylazocalix(4)arene-calix(4)pyrroleMeSH

  structure in first source

• C5795341,3-diacetoxytetradeca-6,12-dien-8,10-diyneMeSH

  isolated from Cyathula officinalis; structure in first source

• C5601461,3-diborata-2,4-diphosphoniocyclobutaneMeSH

  structure in first source

• C5879101,3-dicyclopentyl-1,2,3,6-tetrahydropyrimidine-4,5-dicarboxylic acid diethyl esterMeSH

  structure in first source

• C5597211,3-dihydroxyeudesman-11(13)-en-6,12-olideMeSH

  inhibits nitric oxide production; isolated from Taraxacum mongolicum; structure in first source

• C5597221,3-dihydroxyeudesman-6,12-olideMeSH

  inhibits nitric oxide production; isolated from Taraxacum mongolicum; structure in first source

• C5705311,3-dihydroxypropan-2-yl 11-(2-hexyl-5-hydroxyphenoxy)undecanoateMeSH

  a CB1 receptor ligand; structure in first source

• C5705321,3-dihydroxypropan-2-yl 11-(3-hydroxy-5-(2-methyloctan-2-yl)phenoxy)undecanoateMeSH

  a CB1 receptor ligand; structure in first source

• C5835741,3-dimethyl-2-imidazolidinoneMeSH

  structure in first source

• C5776811,3-dimethyl-3-phenylbutyl acetateMeSH

  structure in first source

• C5777661,3-dimethyl-7-(2-hydroxy-3-(1-piperidino)propyl)-8-phenylxanthineamineMeSH

  has membranotropic activity

• C5719791,3-dimethylamylamineMeSH
• C5770721,3-dipalmitamidopropan-2-yl 2-(trimethylammonio)ethyl phosphateMeSH

  structure in first source

• C5719511,3-diphenyl-3H-indeno(1,2,3-de)pyrazolo(3,4-b)quinolineMeSH

  structure in first source

• C5613721,3-dodecylpyridinium bromideMeSH

  synthetic antineoplastic analog of natural cpd from the marine sponge Reniera sarai; structure in first source

• C5742421,3-oxathiolan-5-oneMeSH

  structure in first source

• C5681781,3a,6a-triazapentaleneMeSH

  structure in first source

• C5680581,4,5,6-tetrahydrocyclopenta(b)pyrroleMeSH

  structure in first source

• C5784391,4,7,10-tetraazacyclododecane-1,4,7,10-tetracetic acidMeSH

  structure in first source

• C5854291,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylene(2-carboxyethyl)phosphinic acid)MeSH

  structure in first souce

• C5613291,4,7,10-tetraazacyclododecane-1,7-diacetic acidMeSH

  structure in first source

• C5812811,4,7-triazacyclononane-1,4,7-tris-(glutaric acid)MeSH

  structure in first source

• C5765031,4,7-triazacyclononane-1-(methyl(2-carboxyethyl)phosphinic acid)-4,7-bis(methyl(2-hydroxymethyl)phosphinic acid)MeSH

  structure in first source

• C5792611,4,7-tris(methylenephosphinic acid)MeSH

  structure in first source

• C5845811,4-O-diferuloylsecoisolariciresinolMeSH

  inhibits mTOR signaling in cancer cells; structure in first source

• D0150611,4-alpha-Glucan Branching EnzymeMeSH

  In glycogen or amylopectin synthesis, the enzyme that catalyzes the transfer of a segment of a 1,4-alpha-glucan chain to a primary hydroxy group in a similar glucan chain. EC 2.4.1.18.

• C5874731,4-anthracenedioneMeSH

  structure in first source

• C5841591,4-bis((hydroxy(phenyl)phosphoryl)methyl)piperazine-1,4-diium tetrachloridocadmate(II) dihydrateMeSH

  structure in first source

• C5841601,4-bis((hydroxy(phenyl)phosphoryl)methyl)piperazine-1,4-diium tetrachloridocobalt(II) dihydrateMeSH

  structure in first source

• C5779451,4-bis(2-(imidazol-4-yl)ethylamino)phthalazineMeSH

  a trypanocidal agent that inhibits iron superoxide dismutase; structure in first source

• C5779471,4-bis(3-(imidazol-1-yl)propylamino)phthalazineMeSH

  a trypanocidal agent that inhibits iron superoxide dismutase; structure in first source

• C5854071,4-bis(4-(3-phenoxypropoxy)but-2-ynyl)piperazineMeSH

  structure in first source

• C5750181,4-bis(N,N-bis(2-picoyl)amino)butaneMeSH
• C5723501,4-bis(di(5-hydroxy-1H-indol-3-yl)methyl)benzeneMeSH

  has antineoplastic activity; structure in first source

• C5602691,4-bis(diphenylchlorostannyl)-p-xyleneMeSH

  has antineoplastic activity; structure in first source

• C5726701,4-bis-(guan-7-yl)-2,3-butanediolMeSH

  structure in first source

• C5812861,4-bisdesoxyquinocetoneMeSH

  cytotoxic and genotoxic